Wall Street Economics is Bad for Innovation
March 23, 2010
By Josh Levine
Learn more about subscribing to Levine�s MicroCap Investor:
http://www.levinesmicrocapinvestor.com/subscriptions/order/
The institutionalization of finance has been good for Wall Street  power brokers, enabling them to concentrate control and profits. But it  has done absolutely nothing to improve the environment for small  innovative companies seeking to raise $5 million, $20 million, or $50  million. In fact, it has sucked capital away from emerging growth firms  and into a mundane mosaic of investments – everything from securitized  mortgages to ETFs of every stripe.
The matra of "bigger is better" means investment bankers,  hedge funds, venture capitalists and others can earn bigger fees, but  it creates a huge vacuum in the system. Too much risk (and intellectual)  capital is being channeled into casino-like trading and a range of  investment gimmicks rather than serving growth companies and research  and development.
The model for funding small innovative firms has been broken for  many years, and the economic and opportunity costs are killing us.
Until a better system emerges, many of the most challenging  economic problems faced by the United States, including terminal  unemployment, decline in leadership of innovation-driven markets, and  shrinking capital markets for emerging growth companies, may never be  fully reversed.
One of the most effective ways to improve the situation is by  changing the incentive system for financing small technology companies.
As two senior advisors at Grant Thornton -- Edward Kim and David  Weild -- correctly point out, markets have become inhospitable to  smaller private companies looking to raise less than $50 million.
CFO magazine, reporting on their recent testimony for a U.S. congressional subcommittee, says:
"The main cause, as they see it, is lower trading fees, stemming  first from online brokerages and new order-handling rules in the late  1990s, and then from decimalization, Sarbanes-Oxley, and the global  research analyst settlement separating research from banking. Given the  lower fees, it no longer makes economic sense for investment banks to  support small-company IPOs with capital and research. Kim says that  small companies 'are not a product anymore; they're just food for  Goldman Sachs's real clients'— hedge funds looking for quick gains  through IPOs…"
Without a major revision of the economic incentives for funding and  supporting small companies, we're stuck with a busted system for  financing innovation. And while the passage of the Small Company Capital  Formation Act of 2011 (a bill that would increase the amount of money  companies can raise in the public markets through Reg A transactions  from $5 million to $50 million) would help the situation, it will fall  far short of what's really needed.
According to Kim, raising the limit to $50 million "would be a  positive step that would reduce some red tape, and one that I think  Congress will pass, but it's just one step of many that would be needed.  I truly believe that without a completely different market model, we  won't fix the problems."
Clearly, there is no simple cure for what ails innovation  financing. While a new Reg A limit would at least be a first step  towards improving market conditions for the companies that have the  potential to transform the U.S. economy, there's much more that can, and  should, be done.
In an upcoming entry for Functional Inspiration, I will explore  some initiatives that could create better opportunities for smaller  companies to access capital and accelerate the development of emerging  technologies into the marketplace.
Subscribe to Functional Inspiration Blog http://www.levinesmicrocapinvestor.com/RSS/Articles.xml
MicroCap Investor  delves deep into the world of small stocks to identify big winners.  Levine targets innovative companies on the path of the new and  revolutionary, developing technologies that disrupt entrenched markets  to create tremendous value.
About Josh Levine and  Levine's MicroCap Investorwww.levinesmicrocapinvestor.com
Josh Levine has 25 years of senior-level experience in analyzing  technology trends and investing in top-performing micro- and small-cap  stocks. He excels at assessing management teams and evaluating new  innovations and their impact on corporate valuations.
In 2002 he joined independent investment-research boutique ChangeWave Research, where he was editor of ChangeWave MicroCap Investor since 2004, becoming Levine's MicroCap Investor in 2010. He has been editor of the flagship ChangeWave Investing since 2007.
Levine is also senior analyst for ChangeWave Research. Through its  survey network comprised of 25,000 members, ChangeWave tracks the rate  of change in corporate and consumer demand trends and provides the  results through an institutional research subscription service. Its  macroeconomic research is among the best on Wall Street.
More on Levine's bio: http://www.levinesmicrocapinvestor.com/aboutus/
Learn more about subscribing to Levine's MicroCap Investor: http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com is partnered with Josh Levine and MicroCap Investor  as part of its mission to provide investors with research tools to  explore the world of small stocks. The InvestorIdeas.com team operates  this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research  portal, with resources covering high-growth sectors including  technology, biotech and cleantech.
Levine's MicroCap Investor
Contact us
admin@levinesmicrocapinvestor.com
800 665 0411
No comments:
Post a Comment